CDK6, MET, NOTCH1, and LRP1B mutation frequencies showed significant differences in cases with (N ≥ 1) or without (N = 0) lymph node metastasis (Figure 1B). This evidence concerns the gene MET and metastatic malignant neoplasm in the lymph nodes.